Amundi Tg Therapeutics, Inc. Transaction History

Amundi

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$5.01 - $11.83 $7,940 - $18,750	-1,585 Reduced 12.59%	11,009 $130,000
Q3 2022 Nov 14, 2022	BUY	$4.57 - $8.4 $57,554 - $105,789	12,594 New	12,594 $79,000
Q2 2022 Aug 15, 2022	SELL	$3.74 - $10.66 $21,415 - $61,039	-5,726 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$32.5 - $48.96 $186,095 - $280,344	5,726 New	5,726 $222,000

354

90.2M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.81B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.